相似文献
1
Efficacy of co-amoxiclav compared with other beta-lactams, quinolones, tetracyclines and erythromycin against an experimental Chlamydia trachomatis respiratory infection.
J Antimicrob Chemother. 1993 Nov;32(5):781-2. doi: 10.1093/jac/32.5.781.
2
Treatment of Chlamydia trachomatis genital infection.
Rev Infect Dis. 1990 Jul-Aug;12 Suppl 6:S645-55. doi: 10.1093/clinids/12.supplement_6.s645.
3
Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid, or azithromycin.
Antimicrob Agents Chemother. 1994 Sep;38(9):1937-43. doi: 10.1128/AAC.38.9.1937.
4
[Augmentin--current and prospective therapeutic indications].
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1988 Jul-Sep;37(3):203-10.
5
Comparative activities of amoxycillin, amoxycillin/clavulanic acid and tetracycline against Chlamydia trachomatis in cell culture and in an experimental mouse pneumonitis.
J Antimicrob Chemother. 1991 May;27(5):627-38. doi: 10.1093/jac/27.5.627.
6
[Chlamydia trachomatis].
Nihon Rinsho. 2003 Feb;61 Suppl 2:485-9.
7
[Comparative study of ofloxacin+amoxicillin-clavulanic acid versus doxycycline+amoxicillin-clavulanic acid combination in the treatment of pelvic Chlamydia trachomatis infections].
J Gynecol Obstet Biol Reprod (Paris). 1995;24(3):253-9.
8
In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis.
Antimicrob Agents Chemother. 1992 Jan;36(1):188-90. doi: 10.1128/AAC.36.1.188.
9
A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections.
J Antimicrob Chemother. 1993 Jun;31 Suppl E:147-52. doi: 10.1093/jac/31.suppl_e.147.
10
Amoxicillin/clavulanate therapy of respiratory tract infections: a microbiologic perspective.
Clin Ther. 1992 May-Jun;14(3):418-25.
Zotero 插件